You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 28, 2025

Drug Price Trends for NDC 60429-0966


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 60429-0966

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug NameVendorNDCCountPrice ($)Price/Unit ($)DatesPrice Type
DOXEPIN HCL 10MG CAP Golden State Medical Supply, Inc. 60429-0966-10 1000 234.00 0.23400 2023-06-15 - 2028-06-14 FSS
DOXEPIN HCL 10MG CAP Golden State Medical Supply, Inc. 60429-0966-01 100 23.88 0.23880 2023-06-15 - 2028-06-14 FSS
>Drug Name>Vendor>NDC>Count>Price ($)>Price/Unit ($)>Dates>Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Showing 1 to 2 of 2 entries

Market Analysis and Price Projections for NDC 60429-0966

Understanding the NDC System

To analyze the market and price projections for a specific drug identified by its National Drug Code (NDC), it is crucial to understand what the NDC represents. The NDC is a unique, three-segment number that identifies the labeler, product, and package size of a drug product. This system is managed by the FDA and is essential for tracking and regulating drug products in the U.S. market[4].

Identifying the Drug

The NDC 60429-0966 corresponds to a specific drug product. However, the provided sources do not directly mention this NDC. To identify the drug, one would typically refer to the FDA's NDC Directory or other pharmaceutical databases. For example, the NDC 60429-0174 is associated with Citalopram Hydrobromide 20mg tablets, but the specific drug for 60429-0966 is not listed in the given sources[2][4].

Market Trends and Price Projections

General Pharmaceutical Market Trends

The pharmaceutical market is subject to various trends and factors that influence drug prices. For instance, the summer 2024 Pharmacy Market Outlook by Vizient Inc. projects a 0% overall drug price inflation rate for 2025, indicating a stable market environment for many drugs. However, this does not account for individual drug price fluctuations, which can be influenced by factors such as supply chain disruptions, regulatory changes, and market demand[3].

Specific Drug Price Analysis

For a specific drug like the one identified by NDC 60429-0966, price projections would typically involve analyzing historical pricing data, market demand, competition, and any recent regulatory or supply chain changes. Here are some steps to consider:

  • Historical Pricing Data: Review past pricing trends for the drug to identify any patterns or anomalies. This can be done using databases that track pharmaceutical prices over time.
  • Market Demand: Assess the current and projected demand for the drug. High demand can drive prices up, while low demand may lead to price reductions.
  • Competition: Evaluate the competitive landscape. The presence of generic alternatives or new entrants in the market can impact pricing.
  • Regulatory Changes: Monitor any regulatory updates or changes in FDA policies that could affect the drug's pricing.

Example from Similar NDC

While the specific NDC 60429-0966 is not provided in the sources, we can look at a similar example. For NDC 60429-0174, which corresponds to Citalopram Hydrobromide 20mg tablets, the price per unit has fluctuated between $0.04218 and $0.03916 over different periods. This indicates that even for established drugs, prices can vary based on market conditions and supplier agreements[2].

Reporting and Validation

For reporting and validation purposes, especially under the Open Payments system, it is crucial that the drug name and NDC match the CMS-approved dataset. Drugs not found in the reference data will fail validation and cannot be submitted. This emphasizes the importance of accurate and up-to-date information when analyzing and projecting prices for specific drugs[1].

Key Takeaways

  • NDC System: The NDC is a critical identifier for drug products, helping in tracking and regulation.
  • Market Trends: General market trends, such as stable inflation rates, do not necessarily reflect individual drug price fluctuations.
  • Specific Analysis: Historical pricing, market demand, competition, and regulatory changes are key factors in projecting prices for a specific drug.
  • Reporting and Validation: Accurate NDC and drug name information is essential for compliance with regulatory requirements.

FAQs

Q: What is the National Drug Code (NDC) and how is it used? A: The NDC is a unique three-segment number identifying the labeler, product, and package size of a drug product. It is used for tracking and regulating drug products in the U.S. market[4].

Q: How do I find the specific drug associated with an NDC? A: You can find the specific drug by referring to the FDA's NDC Directory or other pharmaceutical databases.

Q: What factors influence drug price projections? A: Factors include historical pricing data, market demand, competition, and regulatory changes.

Q: Why is it important to match the CMS-approved dataset for drug reporting? A: Matching the CMS-approved dataset is crucial for validation and submission of payment records under the Open Payments system[1].

Q: Where can I find the latest pharmaceutical market trends and price forecasts? A: Reports such as the Pharmacy Market Outlook by Vizient Inc. provide comprehensive market analysis and price forecasts[3].

Sources

  1. CMS: Drug Name and National Drug Code (NDC) Reference Data Instructions Calendar Year 2024.
  2. DrugPatentWatch: Latest pharmaceutical drug prices and trends for NDC 60429-0174.
  3. Vizient Inc.: Pharmacy Market Outlook Summer 2024.
  4. FDA: National Drug Code Database Background Information.
  5. CDC: IIS | Code Sets | NDC | Vaccines.

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.